Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Adam J. Olszewski. (2022) Ferritin, sex, and the wildfire of inflammation in Hodgkin lymphoma. Leukemia & Lymphoma 63:4, pages 765-767.
Read now
Read now
Gabriela Vera-Lozada, Carolina Minnicelli, Priscilla Segges, Gustavo Stefanoff, Flavia Kristcevic, Joaquin Ezpeleta, Elizabeth Tapia, Gerald Niedobitek, Mário Henrique M. Barros & Rocio Hassan. (2018) Interleukin 10 (IL10) proximal promoter polymorphisms beyond clinical response in classical Hodgkin lymphoma: Exploring the basis for the genetic control of the tumor microenvironment. OncoImmunology 7:5.
Read now
Read now
Ravnit Grewal, Alexandra Irimie, Nasheen Naidoo, Nooroudien Mohamed, Bobe Petrushev, Manogari Chetty, Ciprian Tomuleasa & Emmanuel-Akinola Abayomi. (2018) Hodgkin’s lymphoma and its association with EBV and HIV infection. Critical Reviews in Clinical Laboratory Sciences 55:2, pages 102-114.
Read now
Read now
Martin S. Staege, Stefanie Kewitz, Toralf Bernig, Caspar Kühnöl & Christine Mauz-Körholz. (2015) Prognostic Biomarkers for Hodgkin Lymphoma. Pediatric Hematology and Oncology 32:7, pages 433-454.
Read now
Read now
Olav E. Yri, Per O. Ekstrøm, Vera Hilden, Gustav Gaudernack, Knut Liestøl, Erlend B. Smeland & Harald Holte. (2012) Polymorphisms in genes encoding interleukin-10 and drug metabolizing enzymes GSTP1, GSTT1, GSTA1 and UGT1A1 influence risk and outcome in Hodgkin lymphoma. Leukemia & Lymphoma 53:10, pages 1934-1944.
Read now
Read now
Boris Böll, Peter Borchmann & Volker Diehl. (2010) Emerging drugs for Hodgkin's lymphoma. Expert Opinion on Emerging Drugs 15:4, pages 585-595.
Read now
Read now
Bharti Rathore & Marshall E Kadin. (2010) Hodgkin's lymphoma therapy: past, present, and future. Expert Opinion on Pharmacotherapy 11:17, pages 2891-2906.
Read now
Read now
Otavio C. G. Baiocchi. (2008) Hodgkin lymphoma and interleukin-10: shall we go down from the tip of the iceberg?. Leukemia & Lymphoma 49:11, pages 2031-2032.
Read now
Read now
Articles from other publishers (19)
Poonam Nagpal, Dante B. Descalzi‐Montoya & Niraj Lodhi. (2020)
The circuitry of the tumor microenvironment in adult and pediatric Hodgkin lymphoma: cellular composition, cytokine profile,
EBV
, and exosomes
. Cancer Reports 4:2.
Crossref
Crossref
Jennifer E. Agrusa, Brooks P. Scull, Harshal A. Abhyankar, Howard Lin, Nmazuo W. Ozuah, Rikhia Chakraborty, Olive S. Eckstein, Nitya Gulati, Elmoataz Abdel Fattah, Nader K. El-Mallawany, Rayne H. Rouce, ZoAnn E. Dreyer, Julienne Brackett, Judith F. Margolin, Joseph Lubega, Terzah M. Horton, Catherine M. Bollard, M. Monica Gramatges, Kala Y. Kamdar, Kenneth L. McClain, Tsz-Kwong Man & Carl E. Allen. (2020) Defining the Inflammatory Plasma Proteome in Pediatric Hodgkin Lymphoma. Cancers 12:12, pages 3603.
Crossref
Crossref
Young-Woong Won, Hyewon Lee, Hyeon-Seok Eom, Jin Seok Kim, Cheolwon Suh, Dok Hyun Yoon, Jung Yong Hong, Hye Jin Kang, Jae Hoon Lee, Won Seog Kim, Seok Jin Kim, Won-Sik Lee, Myung Hee Chang, Young Rok Do, Jun Ho Yi, Inho Kim, Jong-Ho Won, Kyoungha Kim, Sung Yong Oh & Jae-Cheol Jo. (2020) A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin’s lymphoma. Annals of Hematology 99:2, pages 255-264.
Crossref
Crossref
Marcus P. Watkins, Michelle A. Fanale & Nancy L. Bartlett. (2018) SOHO State of the Art Updates and Next Questions: Hodgkin Lymphoma. Clinical Lymphoma Myeloma and Leukemia 18:2, pages 81-90.
Crossref
Crossref
Catherine S. Diefenbach, Joseph M. Connors, Jonathan W. Friedberg, John P. Leonard, Brad S. Kahl, Richard F. Little, Lawrence Baizer, Andrew M. Evens, Richard T. Hoppe, Kara M. Kelly, Daniel O. Persky, Anas Younes, Lale Kostakaglu & Nancy L. Bartlett. (2016) Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations. Journal of the National Cancer Institute 109:4, pages djw249.
Crossref
Crossref
Antonino Carbone & Anas YounesCatherine Diefenbach & Christian Steidl. 2015. Hodgkin And Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (Volume 2). Hodgkin And Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (Volume 2)
20
34
.
Tamar Tadmor, Alessia Bari, Luigi Marcheselli, Stefano Sacchi, Ariel Aviv, Luca Baldini, Paolo G. Gobbi, Samantha Pozzi, Paola Ferri, Maria Christina Cox, Nicola Cascavilla, Emilio Iannitto, Massimo Federico & Aaron Polliack. (2015) Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 Patients. Mayo Clinic Proceedings 90:6, pages 756-764.
Crossref
Crossref
Priscilla Brito da Silva, Guilherme Fleury Perini, Luciana de Andrade Pereira, Elyse Moritz Sacconato, Adriana Marques Damasco Penna, Joao Garibaldi, Egyla Cavalcante & Otavio C.G. Baiocchi. (2015) Imbalance of Pro- and Anti-Inflammatory Cytokines in Patients With cHL Persists Despite Treatment Compared With Control Subjects. Clinical Lymphoma Myeloma and Leukemia 15, pages S151-S157.
Crossref
Crossref
Joseph M. Connors. (2015) Risk assessment in the management of newly diagnosed classical Hodgkin lymphoma. Blood 125:11, pages 1693-1702.
Crossref
Crossref
Silke Reinartz, Tim Schumann, Florian Finkernagel, Annika Wortmann, Julia M. Jansen, Wolfgang Meissner, Michael Krause, Anne‐Marie Schwörer, Uwe Wagner, Sabine Müller‐Brüsselbach & Rolf Müller. (2013) Mixed‐polarization phenotype of ascites‐associated macrophages in human ovarian carcinoma: Correlation of CD163 expression, cytokine levels and early relapse. International Journal of Cancer 134:1, pages 32-42.
Crossref
Crossref
Preethi Reddy Marri, Lucy S. Hodge, Matthew J. Maurer, Steven C. Ziesmer, Susan L. Slager, Thomas M. Habermann, Brian K. Link, James R. Cerhan, Anne J. Novak & Stephen M. Ansell. (2013) Prognostic Significance of Pretreatment Serum Cytokines in Classical Hodgkin Lymphoma. Clinical Cancer Research 19:24, pages 6812-6819.
Crossref
Crossref
Ghada Kchour, SA Rahim Rezaee, Reza Farid, Akram Ghantous, Houshang Rafatpanah, Mahdi Tarhini, Mohamad-Mehdi Kooshyar, Hiba El Hajj, Fadwa Berry, Mohamad Mortada, Roudaina Nasser, Abbas Shirdel, Zeina Dassouki, Mohamad Ezzedine, Hossein Rahimi, Ardeshir Ghavamzadeh, Hugues de Thé, Olivier Hermine, Mahmoud Mahmoudi & Ali Bazarbachi. (2013) The combination of arsenic, interferon-alpha, and zidovudine restores an “immunocompetent-like” cytokine expression profile in patients with adult T-cell leukemia lymphoma. Retrovirology 10:1.
Crossref
Crossref
GUANG-HONG GUO, JIN DONG, XIN-HONG YUAN, ZHEN-NAN DONG & YA-PING TIAN. (2013) Clinical evaluation of the levels of 12 cytokines in serum/plasma under various storage conditions using evidence biochip arrays. Molecular Medicine Reports 7:3, pages 775-780.
Crossref
Crossref
Nils SchoofJeremy FranklinRobert FürstThomas ZanderFrederike von BoninFrederic PeyradeLorenz TrümperVolker DiehlAndreas EngertDieter KubeDaniel Re. (2013) Interleukin-10 Gene Polymorphisms are Associated With Freedom From Treatment Failure for Patients With Hodgkin Lymphoma. The Oncologist 18:1, pages 80-89.
Crossref
Crossref
Maria Kowalska, Joanna Tajer, Magdalena Chechlinska, Malgorzata Fuksiewicz, Beata Kotowicz, Ma?gorzata Syczewska, Jan Walewski & Janina Kaminska. (2012) Discriminant analysis involving serum cytokine levels and prediction of the response to therapy of patients with Hodgkin lymphoma. Tumor Biology 33:5, pages 1733-1738.
Crossref
Crossref
Ljubomir R. Jakovic, Biljana S. Mihaljevic, Maja D. Perunicic Jovanovic, Andrija D. Bogdanovic, Bosko M. Andjelic & Vladimir Z. Bumbasirevic. (2012) Prognostic Significance of Bcl-2, Tumor-Associated Macrophages, and Total Neoplastic and Inflammatory Lymph Node Involvement in Advanced Stage Classical Hodgkin’s Lymphoma. Oncology Research and Treatment 35:12, pages 733-739.
Crossref
Crossref
Rafael D Gaiolla, Maria A. C Domingues, Lígia Niéro-Melo & Deilson Elgui de Oliveira. (2011) Serum Levels of Interleukins 6, 10, and 13 Before and After Treatment of Classic Hodgkin Lymphoma. Archives of Pathology & Laboratory Medicine 135:4, pages 483-489.
Crossref
Crossref
Donatella Aldinucci, Annunziata Gloghini, Antonio Pinto, Rosaria De Filippi & Antonino Carbone. (2010) The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape. The Journal of Pathology 221:3, pages 248-263.
Crossref
Crossref
Lara Cattaruzza, Annunziata Gloghini, Karin Olivo, Raffaele Di Francia, Debora Lorenzon, Rosaria De Filippi, Antonino Carbone, Alfonso Colombatti, Antonio Pinto & Donatella Aldinucci. (2009) Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma. International Journal of Cancer 125:5, pages 1092-1101.
Crossref
Crossref